Publications

2024

Brosius I et al. Epidemiological and Clinical Features of Mpox during the Clade Ib outbreak in South-Kivu, Democratic Republic of the Congo: a prospective cohort study. (Preprint: https://doi.org/10.1101/2024.11.18.24316975)

Bangwen E et al. Mpox in the Democratic Republic of Congo: Analysis of National Epidemiological and Laboratory Surveillance Data, 2010 - 2023 (Under revision, Preprint)

Mukadi-Bamuleka D et al. First imported Cases of MPXV Clade Ib in Goma, Democratic Republic of the Congo: Implications for Global Surveillance and Transmission Dynamics. (Submitted, Preprint)

Kinganda-Lusamaki E et al. Clade I mpox virus genomic diversity in the Democratic Republic of the Congo, 2018-2024: Predominance of zoonotic transmission. Cell. 2024 Oct 24:S0092-8674(24)01199-1

Nizigiuimana A et al. Epidemiological analysis of confirmed mpox cases, Burundi, 3 July to 9 September 2024.

Euro Surveill. 2024 Oct;29(42):2400647

Vakaniaki EH et al. Sustained human outbreak of a new MPXV clade I lineage in eastern Democratic Republic of the Congo.  Nat Med. 2024 Oct;30(10):2791-2795

Vakaniaki EH et al. Presumed Transmission of 2 Distinct Monkeypox Virus Variants from Central African Republic to Democratic Republic of the Congo. Emerg Infect Dis. 2024 Oct;30(10):2128-2134

Mbala-Kingebeni P et al. The time is now (again) for mpox containment and elimination in Democratic Republic of the Congo. PLOS Glob Public Health. 2024 Jun 7;4(6):e0003171

Komakech A et al. Africa should research the long-term sequelae of mpox. Lancet Glob Health. 2024 Oct;12(10):e1580-e1581

Nachega et al. The surge of mpox in Africa: a call for action.

Lancet Glob Health. 2024 Jul;12(7):e1086-e1088

Wawima-Bokalanga T et al. Co-circulation of monkeypox virus subclades Ia and Ib in Kinshasa Province, Democratic Republic of the Congo, July to August 2024. Euro Surveill. 2024 Sep;29(38):2400592.

Kalonji T et al. Co-Circulating Monkeypox and Swinepox Viruses, Democratic Republic of the Congo, 2022. 

Emerg Infect Dis. 2024 Apr;30(4):761-765.

2023

Van Dijck C et al. Emergence of mpox in the post-smallpox era-a narrative review on mpox epidemiology. Clin Microbiol Infect. 2023;29(12):1487-1492.

Nachega JB et al. The Human Mpox Global Outbreak: Available Control Tools and the Opportunity to Break a Cycle of Neglect in Endemic Countries. Am J Trop Med Hyg. 2023 Aug 14;109(4):719-724

Mitjà et al. Mpox in people with advanced HIV infection: a global case series.

Lancet. 2023 Mar 18;401(10380):939-949. 

Van Dijck C et al. Beware of drug resistance: Let’s not lose tecovirimat against mpox.

Clin Microbiol Infect. 2024 Mar;30(3):276-278

Mertes H et al. Tecovirimat Resistance in an Immunocompromised Patient With Mpox and Prolonged Viral Shedding. Ann Intern Med. 2023 Aug;176(8):1141-1143

Nachega JB et al. The Human Mpox Global Outbreak: Available Control Tools and the Opportunity to Break a Cycle of Neglect in Endemic Countries. Am J Trop Med Hyg. 2023 Aug 14;109(4):719-724